Clinical Trial Details

EORTC-06012

Back to Clinical Trials Database

Gemtuzumab Ozogamycin (GO) combined with standard intensive chemotherapy versus standard intensive chemotherapy alone for induction/consolidation in patients 61 - 75 years old with previously untreated AML : a randomized phase III trial (AML-17) of the EORTC - LG and the GIMEMA-ALWP

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 25-Sep-2002
Date Step1 close: 13-Aug-2007
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 450
Treatment Cytarabine, Etoposide, Gemtuzumab, Idarubicin, Mitoxantrone
Study Staff
Type of cancer
Participating groups EORTC Leukemia Group
Gruppo Italiano Malattie Ematologiche dell'Adulto
Protocol summary http://clinicaltrials.gov/ct/show/NCT00052299
NCT number NCT00052299
EudraCT 2005-001347-37